Show simple item record

dc.creatorZisman-Ilani, Yaara
dc.creatorShern, David
dc.creatorDeegan, Patricia
dc.creatorKreyenbuhl, Julie
dc.creatorDixon, Lisa
dc.creatorDrake, Robert
dc.creatorTorrey, William
dc.creatorMishra, Manish
dc.creatorGorbenko, Ksenia
dc.creatorElwyn, Glyn
dc.date.accessioned2021-01-14T17:01:55Z
dc.date.available2021-01-14T17:01:55Z
dc.date.issued2018-05-22
dc.identifier.citationZisman-Ilani, Y., Shern, D., Deegan, P., et al. (2018). Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis. BMC Psychiatry, 18(142). https://doi.org/10.1186/s12888-018-1707-x
dc.identifier.issn1471-244X
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/4642
dc.identifier.urihttp://hdl.handle.net/20.500.12613/4660
dc.description.abstractBackground: People with psychosis struggle with decisions about their use of antipsychotics. They often want to reduce the dose or stop, while facing uncertainty regarding the effects these decisions will have on their treatment and recovery. They may also fear raising this issue with clinicians. The purpose of this study was to develop and test a shared decision making (SDM) tool to support patients and clinicians in making decisions about antipsychotics. Methods: A diverse editorial research team developed an Encounter Decision Aid (EDA) for patients and clinicians to use as part of the psychiatric consultation. The EDA was tested using 24 semistructured interviews with participants representing six stakeholder groups: patients with first-episode psychosis, patients with long-term psychosis, family members, psychiatrists, mental health counselors, and administrators. We used inductive and deductive coding of interview transcripts to identify points to revise within three domains: general impression and purpose of the EDA; suggested changes to the content, wording, and appearance; and usability and potential contribution to the psychiatric consultation. Results: An EDA was developed in an iterative process that yielded evidence-based answers to five frequently asked questions about antipsychotic medications. Patients with long-term psychosis and mental health counselors suggested more changes and revisions than patients with first-episode psychosis and psychiatrists. Family members suggested more revisions to the answers about potential risks of stopping or adjusting antipsychotics than other respondents. Conclusions: The EDA was perceived as potentially useful and feasible in psychiatric routine care, especially if presented during the consultation.
dc.format.extent11 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartBMC Psychiatry, Vol. 18
dc.relation.isreferencedbyBMC
dc.rightsAttribution CC BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectShared decision making
dc.subjectDecision aid
dc.subjectDecision support tool
dc.subjectOption grid
dc.subjectPsychosis
dc.subjectAntipsychotic medication
dc.titleContinue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis
dc.typeText
dc.type.genreJournal article
dc.description.departmentRehabilitation Sciences
dc.relation.doihttps://doi.org/10.1186/s12888-018-1707-x
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeTemple University. College of Public Health
dc.creator.orcidZisman-Ilani|0000-0001-6852-2583
dc.temple.creatorZisman-Ilani, Yaara
dc.date.updated2021-01-14T17:01:52Z
refterms.dateFOA2021-01-14T17:01:56Z


Files in this item

Thumbnail
Name:
Continue, adjust, or stop ...
Size:
818.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY